Nasonex

Medicinal product

(Invented) name

Nasonex

Active substance (s)

Mometazono furoatas

Strength

50 µg/dozėje

Pharmaceutical form

nosies purškalas (suspensija)

Route (s) of administration

vartoti į nosį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R01AD09, Mometasone

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2023-03-03

Date of renewal

Documents

1844_Nasonex_2023-03-03.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Dozėje yra	1 dozėje
Mometazono furoatas	50 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
110482	96592	1096592	buteliukas	140 dozių N1		Receptinis	LT/L/23/1844/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-03-03	Registruotas